{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T18:40:04Z","timestamp":1752172804456,"version":"3.41.2"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Moleac Pte Ltd","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>About half of the world population will suffer from a traumatic brain injury (TBI) during their lifetime, of which about 90% of cases are mild TBI. Although up to 40% of adults with mild TBI experience persistent functional deficits, there is no proven-effective treatment to facilitate recovery after it.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>This randomized placebo-controlled multi-centre study was aimed to examine the efficacy of herbal supplement MLC901 on complex attention following mild TBI at 6 months post-randomisation, as a primary outcome measured by CNS Vital signs (CNS-VS). Adults aged 18\u201365 years, who were 1\u201312-months post-mild TBI and experienced cognitive impairment, were randomly assigned to receive either MLC901 two capsules (0.4g\/capsule) or placebo three times a day for 6 months using centralized stratified permuted block randomization. Secondary outcomes: Rivermead Post-Concussion Symptoms Questionnaire (RPQ; neurobehavioral sequelae); Health Related Quality of Life (QOLIBRI); Hospital Anxiety and Depression Scale (HADS); and safety. Mixed effects models of repeated measures with intention to treat analysis were employed. A Least Square Mean Difference (LSMD) from baseline to 3-, 6-, and 9-month follow-up was calculated with 95% confidence intervals (CI).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In the analysis, 182 participants (47.8% females) were included. Multivariable mixed effects model analysis did not reveal significant improvements in complex attention (LSMD\u2009=\u2009\u22121.18 [95% CI \u22125.40; 3.03; p\u2009=\u20090.58]) and other cognitive domains at 6 months in the MLC901 group compared to the Placebo group. There were significant improvements in RPQ, QOLIBRI, anxiety and depression in the MLC901 group compared to the Placebo group at 6 and 9 months (LSMD \u22124.36 [\u22126.46; \u22122.26] and \u22124.07 [\u22126.22; \u22121.92], 4.84 [1.58; 8.10] and 3.74 [0.44; 7.03], \u22121.50 [\u22122.29; \u22120.71 and \u22120.96 [\u22121.84; \u22120.08], \u22121.14 [\u22121.92; \u22120.35] and \u22121.14 [\u22121.94; \u22120.34]), respectively. MLC901 tested was proven safe.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Although the 6-month treatment with MLC901 did not result in a statistically significant difference with placebo for CNS-VS measurement of cognitive domains in individuals with mild TBI, the study showed a clinically and statistically significant improvement in all clinical scales assessed by the investigators.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>ClinicalTrials.gov identifier <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04861688\" xlink:type=\"simple\">NCT04861688<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0310229","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T17:58:39Z","timestamp":1752170319000},"page":"e0310229","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury"],"prefix":"10.1371","volume":"20","author":[{"given":"Pavel I.","family":"Pilipenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3650-3558","authenticated-orcid":true,"given":"Anna A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia V.","family":"Kotsiubinskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera N.","family":"Grigoryeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0169-3956","authenticated-orcid":true,"given":"Alexey Y.","family":"Khrulev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly V.","family":"Skorokhodov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim M.","family":"Gavrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nona N.","family":"Mkrtchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Majdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Valkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Rabarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Barker-Collo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-1740","authenticated-orcid":true,"given":"Valery L.","family":"Feigin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"5","key":"pone.0310229.ref001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","article-title":"The epidemiology and impact of traumatic brain injury: a brief overview","volume":"21","author":"JA Langlois","year":"2006","journal-title":"J Head Trauma Rehabil"},{"issue":"11","key":"pone.0310229.ref002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"AIR Maas","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"pone.0310229.ref003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1474-4422(12)70262-4","article-title":"Incidence of traumatic brain injury in New Zealand: a population-based study","volume":"12","author":"VL Feigin","year":"2013","journal-title":"Lancet Neurol"},{"issue":"5","key":"pone.0310229.ref004","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"B Halliwell","year":"1992","journal-title":"J Neurochem"},{"key":"pone.0310229.ref005","article-title":"Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study","author":"P McMahon","year":"2013","journal-title":"J Neurotrauma"},{"issue":"642","key":"pone.0310229.ref006","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp16X683161","article-title":"Persistent problems 1 year after mild traumatic brain injury: a longitudinal population study in New Zealand","volume":"66","author":"A Theadom","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"3","key":"pone.0310229.ref007","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.yco.0000165601.29047.ae","article-title":"Outcome from mild traumatic brain injury","volume":"18","author":"GL Iverson","year":"2005","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"pone.0310229.ref008","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02699050902748356","article-title":"Prevalence and structure of symptoms at 3 months after mild traumatic brain injury in a national cohort","volume":"23","author":"M Lannsj\u00f6","year":"2009","journal-title":"Brain Inj"},{"issue":"1","key":"pone.0310229.ref009","first-page":"120","article-title":"Long-term outcome in patients with mild traumatic brain injury: a prospective observational study","volume":"71","author":"MA Zumstein","year":"2011","journal-title":"J Trauma"},{"key":"pone.0310229.ref010","doi-asserted-by":"crossref","first-page":"1321239","DOI":"10.3389\/fneur.2024.1321239","article-title":"Effectiveness of biomedical interventions on the chronic stage of traumatic brain injury: a systematic review of randomized controlled trials","volume":"15","author":"K Kawata","year":"2024","journal-title":"Front Neurol"},{"issue":"1","key":"pone.0310229.ref011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11481-014-9570-0","article-title":"Therapeutic efficacy of Neuro AiD\u2122 (MLC 601), a traditional Chinese medicine, in experimental traumatic brain injury","volume":"10","author":"M-C Tsai","year":"2015","journal-title":"J Neuroimmune Pharmacol"},{"key":"pone.0310229.ref012","article-title":"Systematic review and meta-analysis of the efficacy of MLC901 (NeuroAiD IITM) for acute ischemic brain injury in animal models","volume":"26","author":"IGMAR Ranuh","year":"2021","journal-title":"J Evid Based Integr Med"},{"issue":"7","key":"pone.0310229.ref013","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuropharm.2010.01.001","article-title":"Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo","volume":"58","author":"C Heurteaux","year":"2010","journal-title":"Neuropharmacology"},{"issue":"4","key":"pone.0310229.ref014","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neuropharm.2011.05.003","article-title":"MLC901, a traditional Chinese medicine protects the brain against global ischemia","volume":"61","author":"H Quintard","year":"2011","journal-title":"Neuropharmacology"},{"issue":"8","key":"pone.0310229.ref015","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/ene.13653","article-title":"MLC901 (NeuroAiD II\u2122) for cognition after traumatic brain injury: a pilot randomized clinical trial","volume":"25","author":"A Theadom","year":"2018","journal-title":"Eur J Neurol"},{"issue":"4","key":"pone.0310229.ref016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059167","article-title":"Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin injury: the SAMURAI study protocol","volume":"12","author":"P Pilipenko","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"pone.0310229.ref017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.acn.2006.05.007","article-title":"Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs","volume":"21","author":"CT Gualtieri","year":"2006","journal-title":"Arch Clin Neuropsychol"},{"key":"pone.0310229.ref018","volume-title":"American Neuropsychiatric Association Annual Meeting","author":"CT Gualtieri","year":"2004"},{"issue":"9","key":"pone.0310229.ref019","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00868811","article-title":"The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability","volume":"242","author":"NS King","year":"1995","journal-title":"J Neurol"},{"key":"pone.0310229.ref020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/3-211-27577-0_6","article-title":"Assessment of health-related quality of life in persons after traumatic brain injury--development of the Qolibri, a specific measure","volume":"93","author":"QOLIBRI Group","year":"2005","journal-title":"Acta Neurochir Suppl"},{"issue":"2","key":"pone.0310229.ref021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"I Bjelland","year":"2002","journal-title":"J Psychosomatic Res"},{"issue":"6","key":"pone.0310229.ref022","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"AS Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"pone.0310229.ref023","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","year":"2016"},{"issue":"4","key":"pone.0310229.ref024","first-page":"90","article-title":"A computerized test battery sensitive to mild and severe brain injury","volume":"10","author":"CT Gualtieri","year":"2008","journal-title":"Medscape J Med"},{"issue":"1","key":"pone.0310229.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","article-title":"The Cognitive Failures Questionnaire (CFQ) and its correlates","volume":"21","author":"DE Broadbent","year":"1982","journal-title":"Br J Clin Psychol"},{"issue":"7","key":"pone.0310229.ref026","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.acn.2006.05.007","article-title":"Reliability and validity of a computerized neurocognitive test battery, CNS vital signs","volume":"21","author":"CT Gualtieri","year":"2006","journal-title":"Arch Clin Neuropsychol"},{"key":"pone.0310229.ref027","doi-asserted-by":"crossref","first-page":"151379","DOI":"10.1155\/2014\/151379","article-title":"Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery","volume":"2014","author":"A Papathanasiou","year":"2014","journal-title":"ISRN Neurol"},{"issue":"8","key":"pone.0310229.ref028","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1191\/0269215505cr905oa","article-title":"Construct validity and reliability of the Rivermead Post-Concussion Symptoms Questionnaire","volume":"19","author":"S Eyres","year":"2005","journal-title":"Clin Rehabil"},{"issue":"9","key":"pone.0310229.ref029","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00868811","article-title":"The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability","volume":"242","author":"NS King","year":"1995","journal-title":"J Neurol"},{"issue":"1","key":"pone.0310229.ref030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11357-020-00273-2","article-title":"Quality of life after traumatic brain injury: a cross-sectional analysis uncovers age- and sex-related differences over the adult life span","volume":"43","author":"K Rauen","year":"2021","journal-title":"Geroscience"},{"issue":"1","key":"pone.0310229.ref031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/neu.2015.4287","article-title":"Interpreting quality of life after brain injury scores: cross-walk with the short Form-36","volume":"34","author":"L Wilson","year":"2017","journal-title":"J Neurotrauma"},{"issue":"7","key":"pone.0310229.ref032","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/neu.2009.1077","article-title":"Quality of Life after Brain Injury (QOLIBRI): scale validity and correlates of quality of life","volume":"27","author":"N von Steinb\u00fcchel","year":"2010","journal-title":"J Neurotrauma"},{"key":"pone.0310229.ref033","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jad.2008.06.007","article-title":"Validity of the hospital anxiety and depression scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV","volume":"114","author":"R Whelan-Goodinson","year":"2009","journal-title":"J Affect Disord"},{"issue":"1","key":"pone.0310229.ref034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results","volume":"42","author":"C Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"issue":"2","key":"pone.0310229.ref035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"I Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"issue":"3","key":"pone.0310229.ref036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-2607(02)00017-2","article-title":"Bivariate linear mixed models using SAS proc MIXED","volume":"69","author":"R Thi\u00e9baut","year":"2002","journal-title":"Comput Methods Programs Biomed"},{"key":"pone.0310229.ref037","doi-asserted-by":"crossref","first-page":"121095","DOI":"10.1016\/j.jns.2023.121095","article-title":"A double-blind, placebo-controlled, randomised, multi-centre, phase III study of MLC901 (neuroaid) for the treatment of cognitive impairment after mild traumatic brain injury","volume":"455","author":"PI Pilipenko","year":"2023","journal-title":"J Neurol Sci"},{"issue":"20","key":"pone.0310229.ref038","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.3390\/jcm11206224","article-title":"A systematic review of treatments of post-concussion symptoms","volume":"11","author":"C Heslot","year":"2022","journal-title":"J Clin Med"},{"key":"pone.0310229.ref039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12963-015-0037-1","article-title":"Health-related quality of life after TBI: a systematic review of study design, instruments, measurement properties, and outcome","volume":"13","author":"S Polinder","year":"2015","journal-title":"Popul Health Metr"},{"issue":"23","key":"pone.0310229.ref040","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.3390\/jcm10235597","article-title":"Longitudinal analyses of the reciprocity of depression and anxiety after traumatic brain injury and its clinical implications","volume":"10","author":"B Wang","year":"2021","journal-title":"J Clin Med"},{"key":"pone.0310229.ref041","first-page":"5","article-title":"Assessing the outcomes of mild traumatic brain injury through neurocognitive testing","volume":"4","author":"KB Yrysov","year":"2021","journal-title":"Sci Magazine Sci Rev Med Sci"},{"key":"pone.0310229.ref042","doi-asserted-by":"crossref","first-page":"1077858","DOI":"10.3389\/fnins.2023.1077858","article-title":"Cognitive impairment in diffuse axonal injury patients with favorable outcome","volume":"17","author":"W Chen","year":"2023","journal-title":"Front Neurosci"},{"issue":"3","key":"pone.0310229.ref043","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.63.3.418","article-title":"Cognitive sequelae of diffuse axonal injury","volume":"63","author":"R Scheid","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"pone.0310229.ref044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/arclin\/acr087","article-title":"Slowing down after a mild traumatic brain injury: a strategy to improve cognitive task performance?","volume":"27","author":"LJ Ozen","year":"2012","journal-title":"Arch Clin Neuropsychol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T17:58:52Z","timestamp":1752170332000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310229"}},"subtitle":[],"editor":[{"given":"Steven E.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310229","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}